Tianchen Medical released its 2026 interim report. First-half net profit attributable to the parent was 13.74 million yuan, down 71.5% year on year. Operating revenue was 113 million yuan, down 27.4% year on year. Net profit attributable to the parent after deducting non-recurring items was 5.07 million yuan, down 88.5% year on year. Net operating cash flow was 6.83 million yuan, down 81.5% year on year. Earnings per share were 0.17 yuan. In the second quarter, operating revenue was 57.66 million yuan, down 36.2% year on year, and net profit attributable to the parent was 4.05 million yuan, down 88.4% year on year. As of the end of the second quarter, total assets were 664 million yuan, down 1.3% from the end of the previous year, and net assets attributable to the parent were 495 million yuan, down 12.5% from the end of the previous year. The company said its main business has not undergone major changes. Its core business continues to focus on surgical staplers and surgical support products, while increasing research and development efforts and advancing projects such as an integrated intelligent surgical platform.
Touchstone International Medical Science Co LtdFirst-half net profit down 71.5% and revenue down 27.4% year on year.
